狠狠色丁香久久综合婷婷亚洲成人福利在线-欧美日韩在线观看免费-国产99久久久久久免费看-国产欧美在线一区二区三区-欧美精品一区二区三区免费观看-国内精品99亚洲免费高清

      

        

            
		
		
      		
            
			
            
				
            
					
            
						
            
							
            
								
								
            深圳遠揚化學(xué)技術(shù)有限公司
                                                                        
            
										  中級會員 | 第10年									
            
                                    								
            

							
            
						
            
                        

					
            
										
            
						
            
                            							
            
								
            
								
            
									
            15012456311
            
								
            
							
            
                            						
            
					
            
										
				
            
			
            
			
            
				
            
					
				
            
			
            
		
            

		
		 
				
            
			
            
				
			
            
		
            
		
            
			
            
				
            
					
					
            
						
            英國NIBSC標準品主要應(yīng)用在哪些領(lǐng)域
            
						
            
							時間：2016/6/17閱讀：1918
							
            
							
				
				分享：
				
				
						
            						
            
						
            
							 
            英國NIBSC標準品是深圳遠揚化學(xué)技術(shù)有限公司的熱銷產(chǎn)品，主要應(yīng)用在哪些領(lǐng)域呢？
            英國國家生物制品檢定所是WHO的一個標準品供應(yīng)中心實驗室，它的核心工作是制備、保存和分發(fā)WHO用于檢測生物制品質(zhì)量的標準品。NIBSC制備的流感毒株和檢測抗原、抗血清標準品，保障了各廠家順利的研究和生產(chǎn)。NIBSC提供對投入英國市場的生物藥品的獨立測試，尤其是用于英國兒童免疫計劃的疫苗；它同時也是歐盟控制藥品進入歐盟市場的藥品控制實驗室(OMCL)。 如果出現(xiàn)不能滿足藥品存放要求或患者出現(xiàn)不良反應(yīng)等問題，NIBSC 也可對已投入歐盟市場的產(chǎn)品進行檢驗。
            NIBSC 戰(zhàn)略目標：對有關(guān)生物產(chǎn)品的問題給出回復(fù)和建議；提供生物藥品方面的國家科技力量，維持滿足科學(xué)和藥物學(xué)領(lǐng)域新發(fā)展需求的靈活性、專業(yè)知識和設(shè)施；
            作為化驗方法（如量化生物學(xué)活性以及確定生物產(chǎn)品特征和進行安全評估）方面的機構(gòu)運營并得到認同；
            在歐洲生物產(chǎn)品的控制和標準化方面，繼續(xù)發(fā)揮科學(xué)基礎(chǔ)開發(fā)的中心作用；
            在生物藥品法規(guī)的科學(xué)方面幫助社會達成共識，并籍于此，與世界衛(wèi)生組織緊密合作；
            在控制和標準化的關(guān)鍵領(lǐng)域?qū)崿F(xiàn)和維護質(zhì)量鑒定。
            生物藥品控制
            藥品中使用的生物物質(zhì)包括病毒和細菌疫苗、從人類血液提取的產(chǎn)物、荷爾蒙以及其它諸如細胞分裂素和生長素等治療藥物。
            這些生物物質(zhì)對藥物學(xué)和公眾健康做出了巨大貢獻并發(fā)揮著越來越大的作用，它們大大改善了*的疾病預(yù)防、診斷和治療。
             
            英國NIBSC標準品部分產(chǎn)品列表：
            （篇幅有限，更多產(chǎn)品，歡迎進入我司展臺查詢）
            01/491Meningococcal serogroup W polysaccharide
            13/240Influenza Antigen B/Massachusetts/02/2118 (Egg derived)
            12/B623-034QCRFLUAH1N1QC1-Influenza AH1N1 QC32
            95/634Interleukin-95 (Human, rDNA derived)
            10/211Reteplase Reference Material
            12/B623-023QCRFLUAH1N1QC1-Influenza AH1N1 QC21
            13/242Polio Anti Sabin type 25 (inactivated) Serum
            95/587Interleukin-48 (Human, rDNA derived)
            10/107Reteplase Reference Material
            13/202C-Peptide, Human. 57st International Standard.
            95/644Interleukin-105 (Human, rDNA derived)
            12/B623-096QCRFLUAH1N1QC1-Influenza AH1N1 QC94
            13/313Polio Anti Sabin type 96 (inactivated) Serum
            95/556Interleukin-17 (Human, rDNA derived)
            13/317Polio Anti Sabin type 100 (inactivated) Serum
            95/562Interleukin-23 (Human, rDNA derived)
            12/B623-077QCRFLUAH1N1QC1-Influenza AH1N1 QC75
            12/B623-033QCRFLUAH1N1QC1-Influenza AH1N1 QC31
            13/165C-Peptide, Human. 20st International Standard.
            13/248Polio Anti Sabin type 31 (inactivated) Serum
            01/520Meningococcal serogroup W polysaccharide
            10/207Reteplase Reference Material
            03/104-065HTLV-50 (antibody) Monitor Sample
            12/B623-098QCRFLUAH1N1QC1-Influenza AH1N1 QC96
            13/272Polio Anti Sabin type 55 (inactivated) Serum
            03/104-034HTLV-19 (antibody) Monitor Sample
            01/478Meningococcal serogroup W polysaccharide
            95/659Interleukin-120 (Human, rDNA derived)
            95/592Interleukin-53 (Human, rDNA derived)
            95/579Interleukin-40 (Human, rDNA derived)
            13/156Influenza Antigen B/Massachusetts/02/2034 (Egg derived)
            07/339BCG Vaccine of Russian BCG-I sub-strain(66st WHO Reference Reagent)
            95/565Interleukin-26 (Human, rDNA derived)
            01/429Meningococcal serogroup W polysaccharide
            01/441Meningococcal serogroup W polysaccharide
            12/B623-110QCRFLUAH1N1QC1-Influenza AH1N1 QC108
            10/116Reteplase Reference Material
            12/B623-025QCRFLUAH1N1QC1-Influenza AH1N1 QC23
            10/156Reteplase Reference Material
            07/358BCG Vaccine of Russian BCG-I sub-strain(85st WHO Reference Reagent)
            12/B623-020QCRFLUAH1N1QC1-Influenza AH1N1 QC18
            01/497Meningococcal serogroup W polysaccharide
            13/174C-Peptide, Human. 29st International Standard.
            13/196Influenza Antigen B/Massachusetts/02/2074 (Egg derived)
            12/B623-062QCRFLUAH1N1QC1-Influenza AH1N1 QC60
            10/193Reteplase Reference Material
            13/143Influenza Antigen B/Massachusetts/02/2021 (Egg derived)
            07/381BCG Vaccine of Russian BCG-I sub-strain(108st WHO Reference Reagent)
            01/528Meningococcal serogroup W polysaccharide
            03/104-074HTLV-59 (antibody) Monitor Sample
            01/507Meningococcal serogroup W polysaccharide
            01/526Meningococcal serogroup W polysaccharide
            13/167Influenza Antigen B/Massachusetts/02/2045 (Egg derived)
            01/530Meningococcal serogroup W polysaccharide
            13/193Influenza Antigen B/Massachusetts/02/2071 (Egg derived)
            03/104-118HTLV-103 (antibody) Monitor Sample
            03/104-069HTLV-54 (antibody) Monitor Sample
            03/104-083HTLV-68 (antibody) Monitor Sample
            07/318BCG Vaccine of Russian BCG-I sub-strain(45st WHO Reference Reagent)
            12/B623-097QCRFLUAH1N1QC1-Influenza AH1N1 QC95
            10/210Reteplase Reference Material
            13/222Influenza Antigen B/Massachusetts/02/2100 (Egg derived)
            10/140Reteplase Reference Material
            07/291BCG Vaccine of Russian BCG-I sub-strain(18st WHO Reference Reagent)
            13/183Influenza Antigen B/Massachusetts/02/2061 (Egg derived)
            13/224Influenza Antigen B/Massachusetts/02/2102 (Egg derived)
            10/104Reteplase Reference Material
            10/200Reteplase Reference Material
            13/245C-Peptide, Human. 100st International Standard.
            03/104-043HTLV-28 (antibody) Monitor Sample
            07/361BCG Vaccine of Russian BCG-I sub-strain(88st WHO Reference Reagent)
            01/513Meningococcal serogroup W polysaccharide
            03/104-120HTLV-105 (antibody) Monitor Sample
            13/209C-Peptide, Human. 64st International Standard.
            03/104-018HTLV-3 (antibody) Monitor Sample
            95/618Interleukin-79 (Human, rDNA derived)
            07/348BCG Vaccine of Russian BCG-I sub-strain(75st WHO Reference Reagent)
            10/201Reteplase Reference Material
            12/B623-027QCRFLUAH1N1QC1-Influenza AH1N1 QC25
            07/315BCG Vaccine of Russian BCG-I sub-strain(42st WHO Reference Reagent)
            12/B623-040QCRFLUAH1N1QC1-Influenza AH1N1 QC38
            13/187Influenza Antigen B/Massachusetts/02/2065 (Egg derived)
            13/306Polio Anti Sabin type 89 (inactivated) Serum
            03/104-108HTLV-93 (antibody) Monitor Sample
            07/327BCG Vaccine of Russian BCG-I sub-strain(54st WHO Reference Reagent)
            13/158C-Peptide, Human. 13st International Standard.
            12/B623-010QCRFLUAH1N1QC1-Influenza AH1N1 QC8
            07/294BCG Vaccine of Russian BCG-I sub-strain(21st WHO Reference Reagent)
            13/319Polio Anti Sabin type 102 (inactivated) Serum
            03/104-089HTLV-74 (antibody) Monitor Sample
            13/172C-Peptide, Human. 27st International Standard.
            13/224C-Peptide, Human. 79st International Standard.
            01/512Meningococcal serogroup W polysaccharide
            01/469Meningococcal serogroup W polysaccharide
            13/235C-Peptide, Human. 90st International Standard.
            12/B623-082QCRFLUAH1N1QC1-Influenza AH1N1 QC80
            13/151C-Peptide, Human. 6st International Standard.
            13/211C-Peptide, Human. 66st International Standard.
            01/436Meningococcal serogroup W polysaccharide
            10/135Reteplase Reference Material
            03/104-032HTLV-17 (antibody) Monitor Sample
            95/630Interleukin-91 (Human, rDNA derived)
            07/319BCG Vaccine of Russian BCG-I sub-strain(46st WHO Reference Reagent)
            13/240Polio Anti Sabin type 23 (inactivated) Serum
            95/608Interleukin-69 (Human, rDNA derived)
            13/315Polio Anti Sabin type 98 (inactivated) Serum
            95/614Interleukin-75 (Human, rDNA derived)
            07/338BCG Vaccine of Russian BCG-I sub-strain(65st WHO Reference Reagent)
            07/336BCG Vaccine of Russian BCG-I sub-strain(63st WHO Reference Reagent)
            13/174Influenza Antigen B/Massachusetts/02/2052 (Egg derived)
            07/307BCG Vaccine of Russian BCG-I sub-strain(34st WHO Reference Reagent)
            03/104-092HTLV-77 (antibody) Monitor Sample
            95/629Interleukin-90 (Human, rDNA derived)
            13/226Polio Anti Sabin type 9 (inactivated) Serum
            01/532Meningococcal serogroup W polysaccharide
            07/345BCG Vaccine of Russian BCG-I sub-strain(72st WHO Reference Reagent)
            01/476Meningococcal serogroup W polysaccharide
            03/104-101HTLV-86 (antibody) Monitor Sample
            13/216C-Peptide, Human. 71st International Standard.
            13/324Polio Anti Sabin type 107 (inactivated) Serum
            07/275BCG Vaccine of Russian BCG-I sub-strain(2st WHO Reference Reagent)
            13/226Influenza Antigen B/Massachusetts/02/2104 (Egg derived)
            03/104-024HTLV-9 (antibody) Monitor Sample
            01/468Meningococcal serogroup W polysaccharide
            07/325BCG Vaccine of Russian BCG-I sub-strain(52st WHO Reference Reagent)
            12/B623-038QCRFLUAH1N1QC1-Influenza AH1N1 QC36
            12/B623-047QCRFLUAH1N1QC1-Influenza AH1N1 QC45
            13/271Polio Anti Sabin type 54 (inactivated) Serum
            95/610Interleukin-71 (Human, rDNA derived)
            01/450Meningococcal serogroup W polysaccharide
            07/279BCG Vaccine of Russian BCG-I sub-strain(6st WHO Reference Reagent)
            01/442Meningococcal serogroup W polysaccharide
            12/B623-057QCRFLUAH1N1QC1-Influenza AH1N1 QC55
            10/136Reteplase Reference Material
            12/B623-006QCRFLUAH1N1QC1-Influenza AH1N1 QC4
            07/351BCG Vaccine of Russian BCG-I sub-strain(78st WHO Reference Reagent)
            13/178Influenza Antigen B/Massachusetts/02/2056 (Egg derived)
            13/285Polio Anti Sabin type 68 (inactivated) Serum
            03/104-091HTLV-76 (antibody) Monitor Sample
            01/471Meningococcal serogroup W polysaccharide
            13/181C-Peptide, Human. 36st International Standard.
            03/104-095HTLV-80 (antibody) Monitor Sample
            10/110Reteplase Reference Material
            10/143Reteplase Reference Material
            13/137Influenza Antigen B/Massachusetts/02/2015 (Egg derived)
            07/349BCG Vaccine of Russian BCG-I sub-strain(76st WHO Reference Reagent)
            07/304BCG Vaccine of Russian BCG-I sub-strain(31st WHO Reference Reagent)
            13/242C-Peptide, Human. 97st International Standard.
            12/B623-017QCRFLUAH1N1QC1-Influenza AH1N1 QC15
            07/321BCG Vaccine of Russian BCG-I sub-strain(48st WHO Reference Reagent)
            10/115Reteplase Reference Material
            13/228Influenza Antigen B/Massachusetts/02/2106 (Egg derived)
            12/B623-029QCRFLUAH1N1QC1-Influenza AH1N1 QC27
            10/165Reteplase Reference Material
            13/218C-Peptide, Human. 73st International Standard.
            12/B623-070QCRFLUAH1N1QC1-Influenza AH1N1 QC68
            13/200Influenza Antigen B/Massachusetts/02/2078 (Egg derived)
            03/104-084HTLV-69 (antibody) Monitor Sample
            95/624Interleukin-85 (Human, rDNA derived)
            01/499Meningococcal serogroup W polysaccharide
            03/104-098HTLV-83 (antibody) Monitor Sample
            13/235Influenza Antigen B/Massachusetts/02/2113 (Egg derived)
            01/516Meningococcal serogroup W polysaccharide
            13/162C-Peptide, Human. 17st International Standard.
            13/152Influenza Antigen B/Massachusetts/02/2030 (Egg derived)
            
							
							
							
						
            
					
            
				
            
			
            
		
            
		
		
		
		 



  
    
    				
			 
    
    

    

     
      
     
	 

 
	 
	
	
	

            
	
            
		
            
			
            會員登錄
            
			×
		
            
		
            
				
            
					
            
						
						
            請輸入賬號
            
					
            
				
            
				
            
					
            
						
						
            請輸入密碼
            
					
            
				
            
				
            
					
            =
                       
            請輸驗證碼
            
                    
            
				
            
				
            
		
            
	
            

            


            
	
            
		
            
			
            收藏該商鋪
            
			X
		
            
		
            
			
			
            該信息已收藏！
            
			
			
            
                
            
                    
            標簽：
            
                    
            保存成功
            (空格分隔,最多3個,單個標簽最多10個字符)
            
                
            
                
            
                    
            常用：
            
                    
            
                
            
            
            
		
            
	
            

            
	

            
	
            
		
            
			
            提示
            
			X
		
            
		
            
			
            您的留言已提交成功！我們將在第一時間回復(fù)您~
            
		
            
	
            

            

			 

		

		
            
		    														撥打電話
					
										
		
            
		
		
		
		
		
		
		
        
		












    

	
            
		在線留言